Business
South Africa to suspend rollout of AstraZeneca coronavirus vaccine – ABC News
South Africa will suspend the rollout of the AstraZeneca COVID-19 vaccine after trial data shows the jab offers limited protection against mild disease caused by…
South Africa is set to suspend the rollout of the AstraZeneca vaccine after trial data showed the jab offered limited protection against mild disease caused by B.1.351, the coronavirus variant first identified in the country.
Key points:
- Early data from an Oxford University study suggested the AstraZeneca vaccine offered only “minimal protection” against the South Africa variant
- Vaccine lead researcher Sarah Gilbert said the company expected to have a new jab to cope with the variant by September…
Continue Reading
-
Business15 hours ago3 ASX 200 blue chip shares to buy with $3,000 in July
-
General10 hours agoChina hails PM’s ‘personal efforts’ to restore ties
-
Business15 hours ago2 great ASX shares to buy in July: experts
-
Business18 hours agoJP Morgan initiates coverage of Telix Pharmaceuticals. After rising 1,667% in 5 years, is it still a buy?